---
figid: PMC7352656__cancers-12-01587-g001
figtitle: Molecular mechanisms for acquired resistance
organisms:
- Homo sapiens
- Mus musculus
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC7352656
filename: cancers-12-01587-g001.jpg
figlink: pmc/articles/PMC7352656/figure/cancers-12-01587-f001/
number: F1
caption: The molecular mechanisms for acquired resistance. The mechanisms include
  target gene modification, alternative parallel pathway activation, downstream pathway
  activation, and histological/phenotypic transformation. Both the amplification and
  mutations of receptor tyrosine kinases (RTKs) can induce downstream survival signaling
  pathways. Moreover, the direct overexpression and/or mutations of components of
  downstream pathways can also contribute to acquired resistance by assisting tumor
  cell survival. These mechanisms provide potential targets for combination strategies
  for treatment in cases of acquired resistance.
papertitle: 'Current Strategies for Treating NSCLC: From Biological Mechanisms to
  Clinical Treatment.'
reftext: Junnan Li, et al. Cancers (Basel). 2020 Jun;12(6):1587.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6654813
figid_alias: PMC7352656__F1
figtype: Figure
redirect_from: /figures/PMC7352656__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7352656__cancers-12-01587-g001.html
  '@type': Dataset
  description: The molecular mechanisms for acquired resistance. The mechanisms include
    target gene modification, alternative parallel pathway activation, downstream
    pathway activation, and histological/phenotypic transformation. Both the amplification
    and mutations of receptor tyrosine kinases (RTKs) can induce downstream survival
    signaling pathways. Moreover, the direct overexpression and/or mutations of components
    of downstream pathways can also contribute to acquired resistance by assisting
    tumor cell survival. These mechanisms provide potential targets for combination
    strategies for treatment in cases of acquired resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egf
  - Hgf
  - Met
  - Gas6
  - Egfr
  - Igf1r
  - Erbb2
  - Erbb3
  - Axl
  - Itk
  - Slc22a3
  - ras
  - Hras
  - Kras
  - Rem1
  - Pik3r1
  - Pten
  - Zhx2
  - Akt1
  - Stat3
  - Mtor
  - Ephb2
  - Mapk1
  - EGF
  - HGF
  - IL6
  - SOS1
  - GAS6
  - EGFR
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - IGF1R
  - ERBB2
  - ERBB3
  - AXL
  - SCLC1
  - ITK
  - SLC22A3
  - KRAS
  - HRAS
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - STAT3
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - egf
  - celsr1a
  - gas6
  - egfra
  - her2
  - her3
  - axl
  - foxa2
  - rab1ab
  - ptenb
  - stat3
  - mtor
---
